Jonas Brambeck - Industry Advisor
24th of February, 2026 - Oslo, Norway
Rubicon Healthcare Partners (“Rubicon”) is pleased to announce the appointment of Jonas Brambeck as Industry Advisor.
Jonas Brambeck brings more than 25 years of experience in life science investing, company building, and strategic transactions. He joins Rubicon from Industrifonden, one of the Nordics’ leading venture capital investors, where he has led numerous investments and divestments across the life science sector.
Jonas has also served on the boards of multiple private and publicly listed life science companies, contributing deep governance and strategic expertise.
Earlier in his career, Jonas held international roles spanning sales, marketing, and basic research at Bruker Instruments, AstraZeneca, and AkzoNobel, providing him with a broad industrial perspective across the value chain - from scientific innovation to commercial execution. He holds a PhD in organic chemistry from KTH Royal Institute of Technology in Stockholm.
As Industry Advisor, Jonas will support Rubicon in investment evaluation, strategic development of portfolio companies, and engagement with key stakeholders across the Nordic life science ecosystem.